US Broker Ratings

Insmed Incorporated (INSM): Investor Outlook with a 9.94% Upside Potential

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is capturing the attention of investors with its promising pipeline and strong revenue growth. With a market capitalization of..

Cooper Companies, Inc. (COO) Stock Analysis: Evaluating a Potential 18.4% Upside for Investors

The Cooper Companies, Inc. (NYSE: COO) has been a noteworthy player in the healthcare sector, particularly within the medical instruments and supplies industry. With a market cap of $13.94 billion,..

Pfizer, Inc. (PFE) Investor Outlook: Evaluating a 17.5% Potential Upside Amidst a Robust 7.04% Dividend Yield

Pfizer, Inc. (NYSE: PFE), a stalwart in the healthcare sector, continues to draw investor attention with its notable market presence and a tantalizing potential upside of 17.5%. The company’s current..

BioNTech SE (BNTX) Stock Analysis: Navigating a 30.84% Potential Upside with a Strong Buy Rating

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured investor attention with its innovative approach to immunotherapies for cancer and infectious diseases. Headquartered in Mainz, Germany,..

West Pharmaceutical Services (WST) Stock Analysis: Exploring a 29.42% Potential Upside and Robust Growth in the Healthcare Sector

West Pharmaceutical Services, Inc. (NYSE: WST), a prominent player in the healthcare sector, specializes in designing and manufacturing containment and delivery systems for injectable drugs and healthcare products. Headquartered in..

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring a Potential 8.74% Upside and Strong Revenue Growth

Veeva Systems Inc. (VEEV), a leading provider of cloud-based software for the life sciences industry, has been capturing investor attention with its robust growth metrics and potential upside. With a..

Sanofi (SNY) Stock Analysis: Harnessing a 22% Potential Upside Amidst a Strong Dividend Yield

Sanofi (SNY), a prominent player in the global healthcare sector, stands out with its extensive portfolio of therapeutic solutions and vaccines. Headquartered in Paris, France, Sanofi operates in the drug..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Complex Valuations Amidst Healthcare Innovation

Illumina, Inc. (NASDAQ: ILMN), a key player in the diagnostics and research industry, boasts a significant presence in the healthcare sector. With a current market capitalization of $18.63 billion, Illumina..

Centene Corporation (CNC) Stock Analysis: Navigating Growth and Challenges in the Healthcare Sector

Centene Corporation (NYSE: CNC), a healthcare giant in the United States, is a notable player in the healthcare plans industry. With a market capitalization of $18.46 billion, Centene stands as..

BioMarin Pharmaceutical Inc. (BMRN) Investor Outlook: Exploring a 75.86% Potential Upside

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a leading player in the biotechnology sector, presents a compelling opportunity for investors seeking exposure to innovative healthcare solutions targeting rare diseases. With a market..

Solventum Corporation (SOLV) Stock Analysis: Exploring an 18.85% Upside in the Healthcare Sector

Solventum Corporation (NYSE: SOLV) has emerged as a noteworthy player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $12.4 billion, Solventum..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 73.63% Potential Upside in Biotech

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, offers an intriguing investment opportunity with a remarkable potential upside of 73.63%, according to the latest analyst ratings...

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and Impressive Growth Potential

Tenet Healthcare Corporation (NYSE: THC) stands out in the healthcare sector, boasting a market cap of $18.04 billion. This diversified healthcare services company, headquartered in Dallas, Texas, operates through two..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A Healthcare Giant with 21% Potential Upside

For investors eyeing opportunities in the healthcare sector, GE HealthCare Technologies Inc. (NYSE: GEHC) presents a compelling case. With a market capitalization of $33.28 billion, this United States-based company is..

Universal Health Services, Inc. (UHS) Stock Analysis: Evaluating the 7.08% Potential Upside for Investors

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $14.59 billion, this..

Royalty Pharma (RPRX) Stock Analysis: A Biotech Gem with an 18% Upside Potential

Royalty Pharma plc (RPRX) stands as a unique player in the biotechnology sector, strategically positioned at the crossroads of healthcare innovation and financial acumen. As the world’s largest buyer of..

Regeneron Pharmaceuticals (REGN): Investor Outlook on a Biotech Leader with 14.55% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology sector, continues to capture investor interest with its robust pipeline and promising growth prospects. Based in Tarrytown, New York,..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a 12.64% Potential Upside Amidst Healthcare Growth

Smith & Nephew SNATS, Inc. (NYSE: SNN), a prominent player in the healthcare sector specializing in medical devices, presents a compelling opportunity for investors driven by a noteworthy 12.64% potential..

Johnson & Johnson (JNJ) Stock Analysis: Exploring the 6.96% Potential Upside

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to draw investor attention with its robust market presence and promising growth indicators. The company’s market capitalization stands..

AbbVie Inc. (ABBV) Stock Analysis: Exploring a 10% Potential Upside in the Healthcare Giant

AbbVie Inc. (NYSE: ABBV), a leading player in the healthcare sector, stands out with a market capitalization of $387.34 billion. As a prominent biopharmaceutical company, AbbVie engages in the research,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds